Combined inhibition of insulin-like growth factor-1 receptor enhances the effects of gefitinib in a human non-small cell lung cancer resistant cell line

By Qi Hui wei   Shen Zan   Fan Li hong  

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-11 ,pp. : 1091-1095

Spandidos Publications

Access to resources Recommend Favorite

Afatinib in advanced non-small-cell lung cancer

By Di Maio Massimo   Gridelli Cesare   Grossi Francesco   Novello Silvia   de Marinis Filippo  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 493-504

Future Medicine

Access to resources Recommend Favorite

Rare mutations in non-small-cell lung cancer

By D’Arcangelo Manolo   D’Incecco Armida   Cappuzzo Federico  

Future Oncology, Vol. 9, Iss. 5, 2013-05 ,pp. : 699-711

Future Medicine

Access to resources Recommend Favorite

Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors

By Tsuboi Masahiro   Chevalier Thierry  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 161-170

Humana Press, Inc

Access to resources Recommend Favorite

Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer

By Fukuda Minoru   Oka Mikio   Soda Hiroshi   Kinoshita Akitoshi   Fukuda Masaaki   Nagashima Seiji   Kuba Mutsuo   Takatani Hiroshi   Tsurutani Junji   Nakamura Yoichi   Kasai Takashi   Inoue Yuichi   Soejima Yoshifumi   Kohno Shigeru  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 6, 2004-12 ,pp. : 573-577

Springer Publishing Company

Access to resources Recommend Favorite